Fennec Pharmaceuticals ( (TSE:FRX)) just unveiled an update. Fennec Pharmaceuticals announced the pricing of its public offering of 4,666,667 common shares at $7.50 per share, expecting to raise ...
The average one-year price target for Fennec Pharmaceuticals (TSX:FRX) has been revised to $21.57 / share. This is an increase of 10.41% from the prior estimate of $19.53 dated November 16, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results